Low-dose nivolumab plus induction chemotherapy for locally advanced or unresectable head and neck cancer is associated with high response rates and conversion to definitive therapy

  1. Josh Thomas Georgy
  2. Soumya Susan Regi
  3. Rosh Varghese Georgy
  4. Balu Krishna Sasidharan
  5. Anjana Joel
  6. Deepa Susan Joy Philip
  7. Ajoy Oommen John
  8. Divya Bala Thumaty
  9. Praveen Kumar Marimuthu
  10. Prashant Jambunathan
  11. Kovilapu Harikrishna
  12. Zachariah Thomas
  13. N. Jansi Rani
  14. Amit Jiwan Tirkey
  15. Meera Thomas
  16. Rajesh Isiah
  17. Ashish Singh
Read the full article See related articles

Discuss this preprint

Start a discussion What are Sciety discussions?

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

No abstract available

Article activity feed

  1. Version published to 10.1038/s41598-025-19197-y
  2. Version published to 10.21203/rs.3.rs-6388639/v1 on Research Square